after yesterdays agm statement the share price has risen 50% how much upside is left or is this another false dawn?
http://www.alexa.com/data/details/traffic_details/thewellnessshop.co.uk
womans hour link below.
http://www.bbc.co.uk/radio4/womanshour/04/2008_08_mon.shtml

??????????? strange comment even by my standards ..... obviously my wallet makes me a much greater object of desire that you clearly thought ..... Bernie Ecclestone has that magic in spades

'object of desire' ?? jeez, makes the mind boggle ;)

the likes of you and fliper consider me "an object of desire" only on the golf course where a juicy pigeon is perceived!

copy of mail i received a couple of days ago in response to the reuters interview.
xxxxxx

Here is a copy of a response to that question I sent yesterday:


Firstly, thank you for your kind wishes and yes we are obviously delighted at Alan Johnson's announcement yesterday, which of course we are using to ensure the Gov't fulfils its commitment on Beating the Blues - You will recall in March that Patricia Hewitt stood up at the MIND conference and pronounced the availability of BtB in the NHS from April 07, further supported on the NHS Choices website, advising patients to ask their GP's for it.



It is indeed unfortunate, that Reuters chose to use one word from a lengthy interview that could be misconstrued in its inference, but whilst I cannot pre-empt the announcement of our results you should not link "abysmal" take up by the NHS with what I have previously said on the subject of sales. Primary Care Trusts buying on the basis of the now agreed national framework are, of course, not Ultrasis' only customers.



It could well be seen however as fair comment from me that following the aforementioned statements by the Gov't and DH that the only "collective purchase" in the last 6 months was by the East Midlands. Yes it is encouraging that we can still achieve strong sales in the face of this level of uptake but you and I both know that all our efforts in recent year's deserve to come to fruition in this key market and we should continue to apply whatever pressure we can in making this happen - for the benefit of the thousands of patients that would benefit as well as the commercial rewards to shareholders for their investment in this business.



I trust you found this helpful.

Nigel

Ultrasis PLC
23 October 2007


Ultrasis plc

Final results for the year ended 31 July 2007


Highlights

Turnover ahead 27% (42% ahead in the second half) on the previous year at
1,577,000 (2006: 1,243,000)

High renewal rate and strong sales pipeline for 2008 with some forward
contracts already in place

Deferred income of 1,388,000, 1,272,000 of which is revenue recognisable
within the financial year ending 31 July 2008

Group remains debt free. Cash balance of 879,000 (2006: 872,000)

Company is self financing with projected income flows to cover both working
capital and development needs from internal resources

Implementation of Beating the Blues(R) across PCTs expected to benefit from
the additional 170m funding of psychological therapies recently announced
by the Secretary of State

New 'blue chip' customers and partners: Priory Group, ICAS, Turning Point.


For further information please contact:


Ultrasis plc:

Nigel Brabbins, Chief Executive +44 (0) 20 7566 3900

nbrabbins@ultrasis.com

Wave goodbye to any gains you made over the last few weeks lol

yup .... typical sp performance by ULT, except this time i made the mistake of buying them earlier!

from todays times
Ultrasis

Ultrasis is a technology company whose main product, an interactive computer program aimed at treating mental health patients, became available for prescription on the NHS in March.

Ultrasis published its annual figures yesterday, showing a 27 per cent rise in revenues to 1.58 million, indicating that its Beating the Blues treatment is a hit for those doctors aware of its availability as an affordable alternative to the usual range of antidepressant drugs.

Ultrasiss treatment has been endorsed by NICE, the government watchdog that monitors clinical efficacy and cost-effectiveness. The Health Secretary has committed 170 million of extra funding over three years so that all mental health patients can have access to nondrug therapies. NICE calculates that the NHS could save about 128 million a year from switching drug therapy patients to the Beating the Blues cognitive therapy course.

Uptake of the treatment has not been as quick as the company would like. Since March only 24 of the countrys 153 primary care trusts have made Beating the Blues available to GP practices. Doctors are, however, notoriously slow to change prescribing habits. Ultrasis is debt-free, meaning that investors can afford to wait for usage to increase in line with government expectations.

Ultrasis edged down yesterday to 0.95p but should be prescribed as a buy for investors.

from the scotsman
Very little for Ultrasis to feel blue about
HEALTHCARE company Ultrasis yesterday posted a 27 per cent increase in revenues, helped by an announcement from the government that its "Beating the Blues" programme should be available from April 2007 to all patients with mild to moderate depression via their GPs.

In the year to July, turnover was up to 1.58 million from 1.24m the previous year. But pre-tax losses widened over the period to 764,000 from 363,000.

The firm, which has a market capitalisation of 15m, said moves into new markets for its products and continued sales successes had produced a strong cash balance, with no borrowings, and a sales pipeline making Ultrasis "financially secure and self-financing".

The company said it was enjoying success in markets other than the NHS. A recent contract win was with ICAS, a leading employee assistance provider.

Chief executive Nigel Brabbins said: "ICAS is a new customer for Ultrasis, in a significant new market, underlining the substantial potential for Beating the Blues in markets beyond those where it is currently deployed

http://www.communitycare.co.uk/Articles/2007/10/24/106231/therapy-by-computer.html
Therapy by computer

Posted: 24 October 2007

writes Mark Hunter


When the government announced earlier this year that computerised cognitive behavioural therapy (cCBT) would be made available on the NHS, the move was broadly welcomed by mental health charities and service user groups. Several months later, however, there is increasing disquiet at the slow rate at which it is being taken up by primary care trusts and concern is growing that mental health service users are, once again, waiting on promises that will never be delivered.

For years mental health service users have been pressing for greater access to "talking therapies" such as cognitive behavioural therapy (CBT). Used with or instead of drug treatments, these therapies have achieved impressive results - about 50% of patients with depression, for instance, show improvements with CBT that are similar to those of patients treated with antidepressant drugs. Yet a course of CBT requires several face-to-face counselling sessions with a specially trained therapist. With these being somewhat thin on the ground in most cash-strapped PCTs, many patients have either ended up on lengthy waiting lists or been denied the treatment altogether.

However, last week the government announced it would be investing millions in talking therapies, allowing 900,000 more people to be treated by recruiting an extra 3,600 therapists.

But it will be a few years before the benefits of this investment are felt on the ground. In the meantime the development of computerised CBT has been viewed with great interest by mental health specialists, their patients and the government. It was hoped that the techniques of CBT - reducing patients' dysfunctional emotions by altering their behaviour and thinking patterns - could be integrated into an interactive computer programme, thereby offering the benefits of CBT without the need for a therapist.

Initially there was scepticism that this might simply be a way of fobbing patients off with a cut-price version of what is, after all, a highly specialised psychological technique. However, early results using cCBT show remarkable promise and a recent study by City University in London suggested that NHS waiting times for anxiety and depression treatment could be cut by as much as 25% if cCBT was more widely used.

Paul Corry, director of public affairs at mental health charity Rethink, believes that as long as suitable support remains available from mental health professionals, cCBT could play a valuable role in the treatment of mental illness.

"cCBT treatment can be better for some people than the alternative of no treatment," he says. "But it must not be delivered on the cheap. The package must include proper assessment by health professionals and include support with the offer of alternative treatment if cCBT proves ineffective."

Although Corry believes that "in an ideal world, those who need CBT would be able to access it from a trained therapist as and when they need it", he points out that in the real world this rarely happens.

"It can be hard to access, with waiting lists in some places lasting for years. And accessing the treatment in the first place isn't the only challenge. For some people, the time-limited course of sessions available on the NHS is too short and they may not be able to connect with the therapist assigned to them." For these people, cCBT could be a valuable alternative.

Last year the NationalInstitute for Health and Clinical Excellence (Nice) conducted a major review of cCBT in the treatment of depression, anxiety, phobias and obsessive compulsive disorder. While not providing a blanket endorsement of cCBT in the disorders studied, it recommended the use of two particular programmes - Beating the Blues for people with mild and moderate depression and FearFighter for people with panic and phobia (see panel, below).

In March this year, the Departmentof Health's cCBT implementation guidance promised that the two programmes would be offered in every PCT in England. By the end of March each PCT was expected to have undertaken a local needs assessment, bought the software licences, ensured it had enough hardware, trained its staff and developed referral protocols.
Click Here

Patchy uptake

Uptake so far, however, has been patchy. Ultrasis, the manufacturer of Beating the Blues, estimates that 500,000 people have been denied the treatment since Nice's recommendations were published in February 2006.

"Unfortunately there's not been much evidence of [cCBT] being taken up by PCTs and that is very disappointing," says Andrew McCulloch, chief executive of the Mental Health Foundation, who is at a loss to explain why PCTs are so reluctant to adopt a therapy that is much cheaper than long-term drug therapy or therapist-delivered CBT.

"It's hard to say why PCTs aren't taking it up," he says. "It shouldn't be for financial reasons as cCBT is not a hugely expensive therapy and far cheaper than using trained therapists. I think it's more that the idea of cCBT is not yet embedded in the thinking of PCTs. It may also be because there are only two products to choose from."

Indeed, McCulloch believes that the use of cCBT should be extended beyond the current Nice guidance and, in certain circumstances, may be more effective than therapist-delivered CBT.

"It does have certain advantages over face-to-face therapy," he says. "It's more private, you can take it at your own pace and for some people that seems to work better. I'd also like to see more products on the market. For instance there's good evidence that cCBT is useful in the treatment of obsessive compulsive disorder and phobias, so we do need a range of products."

With an estimated six million people in the UK suffering from depression or anxiety disorders, there is a clear demand for therapies such as cCBT. The government last year launched two demonstration sites in Doncaster and Newham dedicated to developing models on how evidence-based psychological services should be adopted. Now may be the ideal moment for the government to ensure that these models, once developed, are actually implemented.

WHAT IS cCBT?

Computerised cognitive behavioural therapy describes a number of approaches by which cognitive behavioural therapy is delivered through an interactive computer programme. The user may access the software through a CD-Rom, over the internet or by telephone. Staff can facilitate the sessions.

The Nice guidance recommends the use of two programmes:

? Beating the Blues, manufactured by Ultrasis, is aimed at people with mild to moderate depression and anxiety. The package comprises a 15-minute introductory video and eight one-hour interactive computer sessions, usually organised weekly. The package also includes homework projects that are completed between sessions and weekly progress reports are made available to the GP or another healthcare professional at the end of each session. The progress reports include anxiety and depression ratings and suicidal tendencies.

? FearFighter, made by ST Solutions, is a computer-based package for phobic, panic and anxiety disorders. The program, which is available online, is divided into nine steps with brief therapist contact and support provided by trained support workers through telephone calls, or e-mails at different intervals throughout treatment. Progress reports are available to the GP or other healthcare professionals and can be accessed at any time over the internet using a clinical outcome and patients' progress monitoring system.

For those in this and interested... this was posted on the iii site on Sun 15:12
Beating the Blues in multiple sclerosis by TYCVUUUUC

"The MS Society is funding a study on the treatment of depression in multiple sclerosis using Beating the Blues. The research will be conducted at the School of Health and Related Research (Sheffield).

Theres a video at the following link

http://www.mssociety.org.uk/research/research_we_fund/symptom_relief_research_initiative/cbt.html

This study aims to explore acceptability and appropriateness of computerised cognitive behavioural therapy for people with MS, as well as estimate its effect on depression and quality of life for people with MS.

Cognitive behavioural therapy (CBT) looks at the way people think and how they deal with problems. It can help overcome depression by focusing on specific, practical problem solving techniques and by helping people develop the coping skills necessary to deal with difficulties related to depression.

Around half of all people with MS experience major depression during the course of their lifetime and this is strongly associated with reduced quality of life. Studies have shown that talking therapies and CBT in particular, can be effective for treatment of depression and have been shown to be effective for people with MS. However, access to psychological services is very limited and varies with geography.

There is evidence to support the effectiveness of computerised CBT (CCBT) which shows that a particular CCBT product called Beating the Blues is more effective than usual care in treatment of depression and recent guidelines from NICE recommend the use of this in the management of mild and moderate depression. CCBT has the potential to be more easily accessed than therapist-led CBT and could therefore benefit more people. However current evidence is based only on use of CCBT by general populations and it is not known how effective or acceptable it is for people with physical disabilities or chronic degenerative conditions such as MS, nor has it been evaluated for use at home.

The study hopes to provide a well researched protocol for a controlled trial of the effectiveness of CCBT in treating depression in people with MS and develop a computerised CBT product in response to the views of people with MS which will specifically benefit them."

Ultrasis PLC
08 November 2007



8 November 2007

Ultrasis plc



BUPA contract



Ultrasis, the provider of computer-delivered, interactive healthcare products
and associated services, is pleased to announce that BUPA has contracted for an
initial 500 treatments of its flagship product Beating the Blues for use within
the BUPA Wellness Programme.



BUPA Wellness is offered to employees by thousands of companies in the UK and is
pioneering the approach of preventative health and wellbeing. Beating the Blues
will be offered as part of the range of psychological services offered to
employees.



Nigel Brabbins, Chief Executive of Ultrasis, said: 'With depression and other
common mental health problems in the workforce becoming an increasing issue we
are delighted to be working with BUPA Wellness to look at how Beating the Blues
can add value to their groundbreaking approach to wellbeing in the workplace.'

http://www.growthcompany.co.uk/news-and-comment/262377/bupa-breats-ultrasis-blues.thtml

08/11/2007
Depressed healthcare minnow Ultrasis has won a contract for its Beating the Blues depression treatment from private medical leader BUPA.

Nigel Brabbins, chief executive of the loss-making concern, says the contract is for 500 patients to be treated around the country under the BUPA Wellness Programme. 'If that works out, we'd expect to agree an annual contract with BUPA,' suggests Brabbins.

He claims that Beating the Blues, which is an eight-week web-based programme based on cognitive behavioural therapy, succeeds with 70 per cent of patients and could therefore save BUPA 'lots of money' on its company health care schemes if adopted across the board. Describing today's deal as a 'taster', he points out that Belfast-based Ultrasis has a National Health Service contract, too, and is talking to other private healthcare providers and backers, such as Canada Life.

Ultrasis, whose shares soared more than tenfold to 3.38p between 2004 and early 2006, can do with some good news. Losses rose 70 per cent to 769,000 in the year to July, though turnover increased 27 per cent to 1.6 million and the company ended its year debt free and with 879,000 cash.

The shares now stand at 1.03p, up 0.04p this morning. They represent a gamble on recovery.

From MoneyAM's Press Roundup:

According to today's Daily Express:
'Ultrasis close to announcing a deal with a leading US provider of medical support'

- Hope those who hold this will make some money on it. I've not had time to research this one.

i am so fingers crossed- have only been waiting for something to happen for the past 2 years..... (toya thx for info)

toya thanks for the info

The info was right Toya.




Ultrasis plc, the provider of computer-delivered, interactive healthcare
products and associated services, has reached an agreement with the developers
of YourCity.MD to promote 'The Wellness Shop' and its products across the top
300 cities in the United States, providing Ultrasis with direct access to
millions of potential customers. The Wellness Shop is Ultrasis's online retail
service, launched in November 2006, which provides quality healthcare products
and services that help people to be more active in managing their own health and
wellbeing.



YourCity.MD is the only online healthcare portal in the U.S. that reaches more
than 300 of the largest U.S. cities with city-specific domain names with the
intuitive .MD extension. YourCity.MD intends to become the most significant
healthcare portal in the U.S. by delivering local, intuitive, relevant and
physician recommended Web sites aimed at connecting both healthcare consumers
and providers. YourCity.MD has been developed by health practitioners and
entrepreneurs Joe Benza, Jr. and Dr. Michael Barber. 'The goal of YourCity.MD is
to improve the quality of healthcare for consumers by offering a healthcare
network combining national reach with a local platform,' said Mr Benza, CEO of
YourCity.MD.



Initially launched in Cincinnati, Ohio, this site receives more than 200,000
hits per month. Now the site is available in more than 300 cities - for a full
list of the cities go to:
http://www.yourcity.md/yourcity/allcities.aspx
.



YourCity.MD sites are free to both doctors and patients, with revenues generated
by advertising and premium services. YourCity.MD research shows that in the U.S.
alone, 116 million people used the Internet to find health information in 2006,
up from 41 million in 2001.




Commenting on the agreement, Nigel Brabbins, Chief Executive of Ultrasis, said '
Joe and Michael have created the perfect opportunity for patients and healthcare
professionals to share knowledge and information on a local level on how to
manage their own healthcare, and this is a perfect fit with the core business of
Ultrasis. We look forward to sharing YourCity.MD's success as they make the
concept more widely available across the United States. We are offering a
special introductory price for The Wellness Shop products for all YourCity.MD
customers which we will also make available within the UK. '





To read more about YourCity.md published in the Business Courier of Cincinnati
go to
http://cincinnati.bizjournals.com/cincinnati/stories/2007/08/20/
story1.html



For further information please contact:



Ultrasis plc:
Nigel Brabbins, Chief Executive +44 (0) 20 7566 3900
nbrabbins@ultrasis.com

www.ultrasis.com

Oh good! Hope it has the desired effect on sp for you all.

News is good but unfortunately it does not warrant any sales-just potential sales. Having said that every bit helps

YourCity.MD LLC said the sites, localized to each city, will reach 98 percent of the health care market in the United States.